If this were a listed small cap spec they would be releasing revenue every so often. And updating us on MSD trial etc etc. Think they will wait on the bombast till the IPO or after. My view to keep the buy in price nice and low for sophs. Just being cynical you could say
- Forums
- ASX - By Stock
- Qbiotics
If this were a listed small cap spec they would be releasing...
-
- There are more pages in this discussion • 1,115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)